Literature DB >> 30643026

Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence.

Catherine Orr1,2, Philip Spechler3, Zhipeng Cao4,5, Matthew Albaugh3, Bader Chaarani3, Scott Mackey3, Deepak D'Souza6, Nicholas Allgaier3, Tobias Banaschewski7, Arun L W Bokde8, Uli Bromberg9, Christian Büchel9, Erin Burke Quinlan10, Patricia Conrod11,12,13, Sylvane Desrivières10, Herta Flor14,15, Vincent Frouin16, Penny Gowland17, Andreas Heinz18, Bernd Ittermann19, Jean-Luc Martinot20, Marie-Laure Paillère Martinot21, Frauke Nees7,14, Dimitri Papadopoulos Orfanos16, Tomáš Paus22, Luise Poustka23,24, Sabina Millenet7, Juliane H Fröhner25, Rajiv Radhakrishnan6, Michael N Smolka25, Henrik Walter18, Robert Whelan4,5, Gunter Schumann10, Alexandra Potter3, Hugh Garavan3.   

Abstract

Rates of cannabis use among adolescents are high, and are increasing concurrent with changes in the legal status of marijuana and societal attitudes regarding its use. Recreational cannabis use is understudied, especially in the adolescent period when neural maturation may make users particularly vulnerable to the effects of Δ-9-tetrahydrocannabinol (THC) on brain structure. In the current study, we used voxel-based morphometry to compare gray matter volume (GMV) in forty-six 14-year-old human adolescents (males and females) with just one or two instances of cannabis use and carefully matched THC-naive controls. We identified extensive regions in the bilateral medial temporal lobes as well as the bilateral posterior cingulate, lingual gyri, and cerebellum that showed greater GMV in the cannabis users. Analysis of longitudinal data confirmed that GMV differences were unlikely to precede cannabis use. GMV in the temporal regions was associated with contemporaneous performance on the Perceptual Reasoning Index and with future generalized anxiety symptoms in the cannabis users. The distribution of GMV effects mapped onto biomarkers of the endogenous cannabinoid system providing insight into possible mechanisms for these effects.SIGNIFICANCE STATEMENT Almost 35% of American 10th graders have reported using cannabis and existing research suggests that initiation of cannabis use in adolescence is associated with long-term neurocognitive effects. We understand very little about the earliest effects of cannabis use, however, because most research is conducted in adults with a heavy pattern of lifetime use. This study presents evidence suggesting structural brain and cognitive effects of just one or two instances of cannabis use in adolescence. Converging evidence suggests a role for the endocannabinoid system in these effects. This research is particularly timely as the legal status of cannabis is changing in many jurisdictions and the perceived risk by youth associated with smoking cannabis has declined in recent years.
Copyright © 2019 the authors 0270-6474/19/391818-11$15.00/0.

Entities:  

Keywords:  adolescent substance use; cannabis; cognition; marijuana; psychopathology; voxel-based morphometry

Mesh:

Year:  2019        PMID: 30643026      PMCID: PMC6407302          DOI: 10.1523/JNEUROSCI.3375-17.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

Review 2.  The endogenous cannabinoid system and brain development.

Authors:  J Fernández-Ruiz; F Berrendero; M L Hernández; J A Ramos
Journal:  Trends Neurosci       Date:  2000-01       Impact factor: 13.837

3.  Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry.

Authors:  Krista Lisdahl Medina; Alecia D Schweinsburg; Mairav Cohen-Zion; Bonnie J Nagel; Susan F Tapert
Journal:  Neurotoxicol Teratol       Date:  2006-12-12       Impact factor: 3.763

4.  Effects of frequent cannabis use on hippocampal activity during an associative memory task.

Authors:  Gerry Jager; Hendrika H Van Hell; Maartje M L De Win; Rene S Kahn; Wim Van Den Brink; Jan M Van Ree; Nick F Ramsey
Journal:  Eur Neuropsychopharmacol       Date:  2006-11-29       Impact factor: 4.600

5.  Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents.

Authors:  Hans-Ulrich Wittchen; Christine Fröhlich; Silke Behrendt; Agnes Günther; Jürgen Rehm; Petra Zimmermann; Roselind Lieb; Axel Perkonigg
Journal:  Drug Alcohol Depend       Date:  2007-01-25       Impact factor: 4.492

6.  A fast diffeomorphic image registration algorithm.

Authors:  John Ashburner
Journal:  Neuroimage       Date:  2007-07-18       Impact factor: 6.556

7.  Delta 9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor.

Authors:  E Downer; B Boland; M Fogarty; V Campbell
Journal:  Neuroreport       Date:  2001-12-21       Impact factor: 1.837

8.  The Development and Well-Being Assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology.

Authors:  R Goodman; T Ford; H Richards; R Gatward; H Meltzer
Journal:  J Child Psychol Psychiatry       Date:  2000-07       Impact factor: 8.982

9.  A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity.

Authors:  Susana Mato; Vivien Chevaleyre; David Robbe; Angel Pazos; Pablo E Castillo; Olivier J Manzoni
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

10.  [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.

Authors:  H Donald Burns; Koen Van Laere; Sandra Sanabria-Bohórquez; Terence G Hamill; Guy Bormans; Wai-si Eng; Ray Gibson; Christine Ryan; Brett Connolly; Shil Patel; Stephen Krause; Amy Vanko; Anne Van Hecken; Patrick Dupont; Inge De Lepeleire; Paul Rothenberg; S Aubrey Stoch; Josee Cote; William K Hagmann; James P Jewell; Linus S Lin; Ping Liu; Mark T Goulet; Keith Gottesdiener; John A Wagner; Jan de Hoon; Luc Mortelmans; Tung M Fong; Richard J Hargreaves
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

View more
  22 in total

Review 1.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

2.  Cannabis as a Gateway Drug for Opioid Use Disorder.

Authors:  Arthur Robin Williams
Journal:  J Law Med Ethics       Date:  2020-06       Impact factor: 1.718

Review 3.  Consequences of Perinatal Cannabis Exposure.

Authors:  Andrew F Scheyer; Miriam Melis; Viviana Trezza; Olivier J J Manzoni
Journal:  Trends Neurosci       Date:  2019-10-08       Impact factor: 13.837

Review 4.  Cannabis and the developing brain: What does the evidence say?

Authors:  Joanna Jacobus; Kelly E Courtney; Elizabeth A Hodgdon; Rachel Baca
Journal:  Birth Defects Res       Date:  2019-08-05       Impact factor: 2.344

Review 5.  The associations of comorbid substance use disorders and psychiatric conditions with adolescent brain structure and function: A review.

Authors:  Danielle S Kroll; Dana E Feldman; Szu-Yung Ariel Wang; Rui Zhang; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  J Neurol Sci       Date:  2020-08-19       Impact factor: 3.181

Review 6.  The Influence of Cannabis and Nicotine Co-use on Neuromaturation: A Systematic Review of Adolescent and Young Adult Studies.

Authors:  Margie Hernandez Mejia; Natasha E Wade; Rachel Baca; Vanessa G Diaz; Joanna Jacobus
Journal:  Biol Psychiatry       Date:  2020-09-29       Impact factor: 13.382

7.  Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis.

Authors:  Nora Penzel; Linda A Antonucci; Linda T Betz; Rachele Sanfelici; Johanna Weiske; Oliver Pogarell; Paul Cumming; Boris B Quednow; Oliver Howes; Peter Falkai; Rachel Upthegrove; Alessandro Bertolino; Stefan Borgwardt; Paolo Brambilla; Rebekka Lencer; Eva Meisenzahl; Marlene Rosen; Theresa Haidl; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Raimo R K Salokangas; Christos Pantelis; Stephen J Wood; Nikolaos Koutsouleris; Joseph Kambeitz
Journal:  Neuropsychopharmacology       Date:  2021-03-03       Impact factor: 7.853

8.  Recent tobacco use has widespread associations with adolescent white matter microstructure.

Authors:  Rachel E Thayer; Natasha S Hansen; Shikha Prashad; Hollis C Karoly; Francesca M Filbey; Angela D Bryan; Sarah W Feldstein Ewing
Journal:  Addict Behav       Date:  2019-10-11       Impact factor: 4.591

Review 9.  Which came first: Cannabis use or deficits in impulse control?

Authors:  Linda Rinehart; Sade Spencer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-08-11       Impact factor: 5.067

10.  Relationships between age at first substance use and persistence of cannabis use and cannabis use disorder.

Authors:  Seán R Millar; Deirdre Mongan; Bobby P Smyth; Ivan J Perry; Brian Galvin
Journal:  BMC Public Health       Date:  2021-05-27       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.